Page last updated: 2024-10-27

fluorouracil and Enteropathy, Exudative

fluorouracil has been researched along with Enteropathy, Exudative in 2 studies

Fluorouracil: A pyrimidine analog that is an antineoplastic antimetabolite. It interferes with DNA synthesis by blocking the THYMIDYLATE SYNTHETASE conversion of deoxyuridylic acid to thymidylic acid.
5-fluorouracil : A nucleobase analogue that is uracil in which the hydrogen at position 5 is replaced by fluorine. It is an antineoplastic agent which acts as an antimetabolite - following conversion to the active deoxynucleotide, it inhibits DNA synthesis (by blocking the conversion of deoxyuridylic acid to thymidylic acid by the cellular enzyme thymidylate synthetase) and so slows tumour growth.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kondo, M2
Nakanishi, K2
Bamba, T2
Hosokawa, K2
Masuda, M1
Tanaka, H1

Other Studies

2 other studies available for fluorouracil and Enteropathy, Exudative

ArticleYear
Experimental protein-losing gastroenteropathy: role of tissue plasminogen activator.
    Gastroenterology, 1976, Volume: 71, Issue:4

    Topics: Animals; Fibrinolysin; Fibrinolysis; Fluorouracil; Intestinal Mucosa; Ligation; Male; Povidone; Prot

1976
[Local fibrinolytic activity of the digestive tract mucosa--II. Protein-losing gastroenteropathy].
    Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 1975, Volume: 72, Issue:4

    Topics: Animals; Female; Fibrinolysis; Fluorouracil; Gastric Mucosa; Intestinal Mucosa; Male; Mice; Protein-

1975